TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Roivant Sciences Ltd (ROIV)

Healthcare Biotechnology
33.30 $
-1.7% vs. previous close
Closing price · As of: 3. Aug 2026

Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 5,728 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet ROIV
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
2,137 2,066 7,313 7,222 6,206 6,206 5,792 5,437 5,033 5,063 5,225 5,728
1,561 1,552 6,807 6,732 5,801 5,801 5,364 5,000 4,616 4,512 4,660 5,167
1,439 1,414 6,671 6,536 1,959 1,959 1,991 2,715 1,238 1,237 1,478 1,423
1,439 1,414 6,671 6,541 5,387 5,387 5,147 4,887 4,503 4,386 4,530 4,296
40 55 63 83 23 23 144 790
4.2 4.9 5.2 35 34 -193
36 73
145 141 150 138 136
803 740 728 774 626 626 256 250 217 257 251 436
245 266 245 267 556 556 141 149 114 134 152 281
56 60 56 22 9.5 9.5 9.8 9.8 9.4 9.0 10 11
50 44 35 53 25 25 24 24 12 15 13 18
385 389 403 431 312
911 949 6,090 5,969 5,153 5,153 5,189 4,688 4,346 4,362 4,269 4,527
-4,065 -4,369 727 576 396 396 460 116 -316 -429 -695 -502
759 770 844 803 735 735 723 707 680 681 697 812

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?